These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 33275291)

  • 1. Tumor-derived exosomes in the PD-1/PD-L1 axis: Significant regulators as well as promising clinical targets.
    Liang B; Hu X; Ding Y; Liu M
    J Cell Physiol; 2021 Jun; 236(6):4138-4151. PubMed ID: 33275291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment.
    Hudson K; Cross N; Jordan-Mahy N; Leyland R
    Front Immunol; 2020; 11():568931. PubMed ID: 33193345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights into the regulation of exosomal PD-L1 in cancer: From generation to clinical application.
    Liu J; Qin J; Liang L; Zhang X; Gao J; Hao Y; Zhao P
    Eur J Pharmacol; 2024 Sep; 979():176831. PubMed ID: 39047964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response.
    Chen G; Huang AC; Zhang W; Zhang G; Wu M; Xu W; Yu Z; Yang J; Wang B; Sun H; Xia H; Man Q; Zhong W; Antelo LF; Wu B; Xiong X; Liu X; Guan L; Li T; Liu S; Yang R; Lu Y; Dong L; McGettigan S; Somasundaram R; Radhakrishnan R; Mills G; Lu Y; Kim J; Chen YH; Dong H; Zhao Y; Karakousis GC; Mitchell TC; Schuchter LM; Herlyn M; Wherry EJ; Xu X; Guo W
    Nature; 2018 Aug; 560(7718):382-386. PubMed ID: 30089911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.
    Hack SP; Zhu AX; Wang Y
    Front Immunol; 2020; 11():598877. PubMed ID: 33250900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal PD-L1 in cancer and other fields: recent advances and perspectives.
    Lu MM; Yang Y
    Front Immunol; 2024; 15():1395332. PubMed ID: 38726017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell-derived exosomes in CD8
    Gholami A
    Int Immunopharmacol; 2024 Aug; 137():112509. PubMed ID: 38889509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects.
    Munari E; Mariotti FR; Quatrini L; Bertoglio P; Tumino N; Vacca P; Eccher A; Ciompi F; Brunelli M; Martignoni G; Bogina G; Moretta L
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1/PD-L1 axis: implications in immune regulation, cancer progression, and translational applications.
    Ortega MA; Boaru DL; De Leon-Oliva D; Fraile-Martinez O; García-Montero C; Rios L; Garrido-Gil MJ; Barrena-Blázquez S; Minaya-Bravo AM; Rios-Parra A; Álvarez-Mon M; Jiménez-Álvarez L; López-González L; Guijarro LG; Diaz R; Saez MA
    J Mol Med (Berl); 2024 Aug; 102(8):987-1000. PubMed ID: 38935130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Escape Mediated by Exosomal PD-L1 in Cancer.
    Lawler SE; Nowicki MO; Ricklefs FL; Chiocca EA
    Adv Biosyst; 2020 Dec; 4(12):e2000017. PubMed ID: 32383351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmed Cell Death Ligand 1 (PD-L1) Immunohistochemical Expression in Advanced Urothelial Bladder Carcinoma: An Updated Review with Clinical and Pathological Implications.
    Germanà E; Pepe L; Pizzimenti C; Ballato M; Pierconti F; Tuccari G; Ieni A; Giuffrè G; Fadda G; Fiorentino V; Martini M
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer.
    Wu Y; Fu H; Hao J; Yang Z; Qiao X; Li Y; Zhao R; Lin T; Wang Y; Wang M
    Front Immunol; 2024; 15():1342728. PubMed ID: 38562933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory.
    Poggio M; Hu T; Pai CC; Chu B; Belair CD; Chang A; Montabana E; Lang UE; Fu Q; Fong L; Blelloch R
    Cell; 2019 Apr; 177(2):414-427.e13. PubMed ID: 30951669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of programmed death-ligand 1 expression in response to DNA damage in cancer cells: Implications for precision medicine.
    Sato H; Jeggo PA; Shibata A
    Cancer Sci; 2019 Nov; 110(11):3415-3423. PubMed ID: 31513320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy.
    Bocanegra A; Blanco E; Fernandez-Hinojal G; Arasanz H; Chocarro L; Zuazo M; Morente P; Vera R; Escors D; Kochan G
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing PD-L1 Expression by Degraders and Downregulators as a Novel Strategy to Target the PD-1/PD-L1 Pathway.
    Wang Z; Yuan L; Liao X; Guo X; Chen J
    J Med Chem; 2024 Apr; 67(8):6027-6043. PubMed ID: 38598179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune landscape and therapeutic strategies: new insights into PD-L1 in tumors.
    Wei Y; Xiao X; Lao XM; Zheng L; Kuang DM
    Cell Mol Life Sci; 2021 Feb; 78(3):867-887. PubMed ID: 32940722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway.
    Wu Q; Jiang L; Li SC; He QJ; Yang B; Cao J
    Acta Pharmacol Sin; 2021 Jan; 42(1):1-9. PubMed ID: 32152439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of circulating exosomal PD-L1 contributes to immune escape of hepatocellular carcinoma and immune clearance of chronic hepatitis B.
    Lin X; Shao H; Tang Y; Wang Q; Yang Z; Wu H; Xing T
    Aging (Albany NY); 2024 Jul; 16(14):11373-11384. PubMed ID: 39028365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and Function of the PD-L1 Checkpoint.
    Sun C; Mezzadra R; Schumacher TN
    Immunity; 2018 Mar; 48(3):434-452. PubMed ID: 29562194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.